statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Bitcoin

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Invesco QQQ Trust Series 1

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

InvestorPlace - Stock Market News, Stock Advice & Trading Tips
VVOS stock results show that Vivos Therapeutics missed analyst estimates for earnings per share and missed on revenue for the fourth...

VVOS Stock Earnings: Vivos Therapeutics Misses EPS, Misses Revenue for Q4 2023

Vivos Therapeutics, Inc. (VVOS) Q4 2023 Earnings Call Transcript...

Vivos Therapeutics, Inc. (VVOS) Q4 2023 Earnings Call Transcript

Q4 2023 Vivos Therapeutics Inc Earnings Call Transcript

Call Scheduled for Today, Thursday, March 28, 2024 at 5:00 pm ETLITTLETON, Colo., March 28, 2024 (GLOBE NEWSWIRE) -- Vivos Therapeutics, Inc. ( Vivos or the Company ) (NASDAQ: VVOS), a leading...

Vivos Therapeutics Schedules Release of Fourth Quarter and Full Year 2023 Financial Results and Conference Call

See the rest of the story here.

thefly.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fly's real-time, streaming news feed keeps individual...

Vivos Therapeutics reports FY EPS ($11.14),  two estimates ($10.51)

Positive Business Momentum and Sales Pipeline Growth Following FDA 510(k) Clearance of Vivos' Proprietary Oral Medical Devices to Treat Severe Obstructive Sleep Apnea Annual Operating Expenses...

Vivos Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Operational Update

Vivos Therapeutics, Inc. (NASDAQ:VVOS  Get Free Report) was the target of a large decline in short interest in the month of February. As of February 29th, there was short interest totalling...

Vivos Therapeutics, Inc. (NASDAQ:VVOS) Sees Significant Drop in Short Interest

Vivos Therapeutics, Inc. (NASDAQ:VVOS  Get Free Report) was the target of a large decline in short interest in the month of February. As of February 15th, there was short interest totalling...

Vivos Therapeutics, Inc. (NASDAQ:VVOS) Short Interest Down 38.1% in February

Vivos Therapeutics announces exercise of warrants for proceeds of $4M...

Vivos Therapeutics announces exercise of warrants for proceeds of $4M

Vivos Therapeutics, Inc. is a medical technology company which engages in the development and commercialization of treatment alternatives for patients with sleep disordered breathing (SDB). Its solutions are also offered for patients with mild-to-moderate obstructive sleep apnea (OSA). The company was founded by Gurdev Dave Singh, Susan McCullough, RaeAnn Byrnes, Todd Huntsman, and R. Kirk Huntsman on July 7, 2016 and is headquartered in Littleton, CO.

Volume	67,574.00
52-Wk High	$48.79
52-Wk Low	$2.37

Period	Estimated	Reported	Surprise	Result
Q1'24	-$1.18	--	--	N/A
Q4'23	-$1.91	-$3.14	-64.83%	MISSED
Q3'23	-$3.00	-$1.75	41.67%	BEAT
Q2'23	-$3.63	-$4.50	-24.14%	MISSED
Q1'23	-$4.50	-$1.75	61.11%	BEAT

VVOS Vivos Therapeutics Inc

About

Feed

News

Earnings

Fundamentals